{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:52:21Z","timestamp":1784119941569,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T00:00:00Z","timestamp":1665792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12029-022-00864-6","type":"journal-article","created":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T18:02:36Z","timestamp":1665856956000},"page":"693-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer"],"prefix":"10.1007","volume":"54","author":[{"given":"Pengkhun","family":"Nov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5875-5911","authenticated-orcid":false,"given":"Jiqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,15]]},"reference":[{"key":"864_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics. CA Cancer J Clin. 2020;70:145\u201364.","journal-title":"CA Cancer J Clin"},{"key":"864_CR2","doi-asserted-by":"crossref","unstructured":"De Felice F, et al. Total neoadjuvant treatment in locally advanced rectal cancer, Transl Oncol.\u00a02021.","DOI":"10.1016\/j.tranon.2021.101044"},{"key":"864_CR3","first-page":"7476","volume":"28","author":"JC Kong","year":"2021","unstructured":"Kong JC, et al. Ann Surg Oncol. Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and meta analysis of oncological and operative outcomes. 2021;28:7476\u201386.","journal-title":"Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and meta analysis of oncological and operative outcomes"},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(09)70381-X","volume":"11","author":"YJ Chua","year":"2010","unstructured":"Chua YJ, Barbachano Y, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol. 2010;11:241\u20138.","journal-title":"Lancet Oncol"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ijrobp.2014.07.021","volume":"90","author":"YH Gao","year":"2014","unstructured":"Gao YH, Lin JZ, An X, et al. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial. Int J Radiat Oncol Biol Phys. 2014;90:1153\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"864_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.0071","volume":"4","author":"A Cercek","year":"2018","unstructured":"Cercek A, Roxburgh CSD, Strombom P, et al. Adoption of total neoadjuvant therapy for locally advanced rectal cancer. JAMA Oncol. 2018;4: e180071.","journal-title":"JAMA Oncol"},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/cncr.30600","volume":"123","author":"EB Ludmir","year":"2017","unstructured":"Ludmir EB, et al. Total neoadjuvant therapy for rectal cancer: an emerging option. Cancer. 2017;123:1497\u2013506.","journal-title":"Cancer."},{"key":"864_CR8","first-page":"708","volume":"87","author":"H Gilshtein","year":"2021","unstructured":"Gilshtein H, Ghuman A, Dawoud M, Yellinek S, Kent I, Sharp SP, et al.\u00a0Total Neoadjuvant Treatment for Rectal Cancer: Preliminary Experience. Ann Surg. 2021;87:708\u201313.","journal-title":"Ann Surg."},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.6004\/jnccn.2014.0056","volume":"12","author":"A Cercek","year":"2014","unstructured":"Cercek A, Goodman KA, Hajj C, et al. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw. 2014;12:513\u20139.","journal-title":"J Natl Compr Canc Netw"},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1200\/JCO.2005.04.4875","volume":"24","author":"I Chau","year":"2006","unstructured":"Chau I, Brown G, Cunningham D, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol. 2006;24:668\u201374.","journal-title":"J Clin Oncol"},{"key":"864_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"C Fernandez-Martos","year":"2010","unstructured":"Fernandez-Martos C, Pericay C, Aparicio J, et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study. J Clin Oncol. 2010;28:859\u201365.","journal-title":"J Clin Oncol"},{"key":"864_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/COC.0000000000000149","volume":"40","author":"K Perez","year":"2017","unstructured":"Perez K, Safran H, Sikov W, et al. Complete neoadjuvant treatment of rectal cancer: the Brown University Oncology Group CONTRE study. Am J Clin Oncol. 2017;40:283\u20137.","journal-title":"Am J Clin Oncol"},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ijrobp.2018.04.013","volume":"101","author":"SY Kim","year":"2018","unstructured":"Kim SY, Joo J, Kim TW, et al. A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: KCSG CO 14\u201303. Int J Radiat Oncol Biol Phys. 2018;101:889\u201399.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1634\/theoncologist.2010-0285","volume":"16","author":"M Nogue","year":"2011","unstructured":"Nogue M, Salud A, Vicente P, et al. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study. Oncologist. 2011;16:614\u201320.","journal-title":"Oncologist"},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/annonc\/mdv223","volume":"26","author":"C Fernandez-Martos","year":"2015","unstructured":"Fernandez-Martos C, Garcia-Albeniz X, Pericay C, et al. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomised trial. Ann Oncol. 2015;26:1722\u20138.","journal-title":"Ann Oncol"},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1093\/annonc\/mdr473","volume":"23","author":"R Marechal","year":"2012","unstructured":"Marechal R, Vos B, Polus M, et al. Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomised multicentric phase II study. Ann Oncol. 2012;23:1525\u201330.","journal-title":"Ann Oncol"},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/annonc\/mdw215","volume":"27","author":"F Sclafani","year":"2016","unstructured":"Sclafani F, Brown G, Cunningham D, et al. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer. Ann Oncol. 2016;27:1557\u201365.","journal-title":"Ann Oncol"},{"key":"864_CR18","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022;2546\u201356."},{"key":"864_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29\u201342.","journal-title":"Lancet Oncol"},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702\u201315.","journal-title":"Lancet Oncol"},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1200\/JCO.19.00308","volume":"37","author":"E Fokas","year":"2019","unstructured":"Fokas E, Allga\u00a8uer M, Polat B, et al. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Clin Oncol. 2019;37:3712\u20133222.","journal-title":"J Clin Oncol"},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.radonc.2020.11.008","volume":"155","author":"A Garant","year":"2021","unstructured":"Garant A, Kavan P, Martin AG, et al. Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: the KIR randomized phase II trial. Radiother Oncol. 2021;155:237\u201345.","journal-title":"Radiother Oncol"},{"key":"864_CR23","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/DCR.0000000000001207","volume":"61","author":"MR Marco","year":"2018","unstructured":"Marco MR, Zhou L, Patil S, et al. Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter phase II trial. Dis Colon Rectum. 2018;61:1146\u201355.","journal-title":"Dis Colon Rectum"},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/annonc\/mdw062","volume":"27","author":"K Bujko","year":"2016","unstructured":"Bujko K, Wyrwicz L, Rutkowski A, et al. Long-course oxaliplatin-based preoperative chemoradiation versus 535 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol. 2016;27:834\u201342.","journal-title":"Ann Oncol"},{"key":"864_CR25","unstructured":"Nilsson PJ, van Etten B, Hospers GA, et al. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer 201313:279."},{"issue":"3","key":"864_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2478\/raon-2018-0028","volume":"52","author":"D Golo","year":"2018","unstructured":"Golo D, But-Hadzic J, Anderluh F, Brecelj E, Edhemovic I, Jeromen A, Omejc M, Oblak I, Secerov-Ermenc A, Velenik V. Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial. Radiol Oncol. 2018;52(3):267\u201374.","journal-title":"Radiol Oncol"},{"issue":"4","key":"864_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/bjs.10694","volume":"105","author":"DMGI van Zoggel","year":"2018","unstructured":"van Zoggel DMGI, Bosman SJ, Kusters M, et al. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer. Br J Surg. 2018;105(4):447\u201352.","journal-title":"Br J Surg"},{"issue":"suppl 15","key":"864_CR28","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1200\/JCO.2020.38.15_suppl.4007","volume":"38","author":"T Conroy","year":"2020","unstructured":"Conroy T, Lamfichekh N, Etienne P-L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: final results of PRODIGE 23 phase III trial, a UNICANCER GI trial. J Clin Oncol. 2020;38(suppl 15):4007.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-022-00864-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-022-00864-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-022-00864-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T07:34:25Z","timestamp":1698478465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-022-00864-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1007\/s12029-022-00864-6","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,15]]},"assertion":[{"value":"9 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the authors of the article agreed to be published in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}